NCT04887532View on ClinicalTrials.gov

A Trial of HR19042 Capsule in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

July 27, 2021

Study Completion Date

July 27, 2021

Conditions

Primary IgA Nephropathy

Interventions

DRUG

HR19042 capsule

phase 1 :8mg; phase 2:12mg; phase 3:16mg

Trial Locations (1)

200231

Shanghai Xuhui Central Hospital, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY